Malignant Anal Canal Neoplasm — Trials

Malignant Anal Canal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

23 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04499352	A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer	withdrawn	Phase 2	0	Boehringer IngelheimINDUSTRY	1	Nov 15, 2021	clinicaltrials
NCT03942900	Immunomonitoring and Biomarker Research in Patients With Squamous Cell Anal Carcinoma(LAND)	withdrawn	—	0	Centre Hospitalier Universitaire de BesanconOTHER	1	Jul 30, 2021